United States · FDA National Drug Code directory
Pyrazinamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-447_3695f057-de86-4c9a-9d43-ff0a6acdffe7
- Product NDC
- 33342-447
- Form
- TABLET
- Composition / generic term
- Pyrazinamide
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200727
- Source listing expiry
- 20261231
Source-listed ingredients
- PYRAZINAMIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (33342-447-03) · 33342-447-03
- 30 TABLET in 1 BOTTLE (33342-447-07) · 33342-447-07
- 60 TABLET in 1 BOTTLE (33342-447-09) · 33342-447-09
- 90 TABLET in 1 BOTTLE (33342-447-10) · 33342-447-10
- 100 TABLET in 1 BOTTLE (33342-447-11) · 33342-447-11
- 10 TABLET in 1 BLISTER PACK (33342-447-12) · 33342-447-12
- 500 TABLET in 1 BOTTLE (33342-447-15) · 33342-447-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →